|
|
|
Volumn 33 Suppl 1, Issue , 2006, Pages 75-78
|
|
Irinotecan plus oral S-1 in patients with advanced gastric cancer-biweekly IRIS regimen
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
DRUG DERIVATIVE;
IRINOTECAN;
OXONIC ACID;
S 1 (COMBINATION);
TEGAFUR;
ADULT;
AGED;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DIARRHEA;
DRUG ADMINISTRATION;
DRUG COMBINATION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MICROCAPSULE;
MIDDLE AGED;
MORTALITY;
NAUSEA;
ORAL DRUG ADMINISTRATION;
PATHOLOGY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
QUALITY OF LIFE;
STOMACH TUMOR;
SURVIVAL RATE;
ADMINISTRATION, ORAL;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
CAPSULES;
DIARRHEA;
DRUG ADMINISTRATION SCHEDULE;
DRUG COMBINATIONS;
HUMANS;
INFUSIONS, INTRAVENOUS;
MIDDLE AGED;
NAUSEA;
OXONIC ACID;
QUALITY OF LIFE;
STOMACH NEOPLASMS;
SURVIVAL RATE;
TEGAFUR;
|
|
EID: 33747400517
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
